Register
|
Login
The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
NEWS
CONFERENCES
VIDEOS
Case-Based Peer Perspectives
Expert Perspective Virtual Tumor Board
Interviews
Investigator Perspectives
Precision Medicine
PUBLICATIONS
Evolving Paradigms
Targeted Therapies in Oncology
The Journal of Targeted Therapies in Cancer
ONCAlert | Upfront Therapy for mRCC
Specialties >>
Acute Myeloid Leukemia
Biosimilars
Bladder Cancer
Brain Cancer
Breast Cancer
Chronic Lymphocytic Leukemia
Colorectal Cancer
Diffuse Large B-Cell Lymphoma
Follicular Lymphoma
Gastric Cancer
Gastrointestinal Cancers
Genitourinary Cancers
Gynecologic Cancers
Head and Neck Cancers
Hematology
Hepatocellular Carcinoma
Immunotherapy
Lung Cancer
Lymphomas
Mantle Cell Lymphoma
Melanoma
Multiple Myeloma
Myeloproliferative Neoplasms
Ovarian Cancer
Prostate Cancer
Renal Cell Carcinoma
Skin Cancers
Soft Tissue Sarcoma
Thyroid Cancers
Partners >>
Dialogues in Diagnostics
Differential Diagnosis
Case-Based Peer Perspectives
Email Sign-Up
Targeted Therapies: Lung Cancer
2015
|
2014
|
2012
Lung Cancer (January 2015)
Lung Cancer (May 2014)
Lung Cancer (Sept 2014)
Lung Cancer (May 2012)
JTT Articles
The Role of JAK2 Inhibition in Polycythemia Vera
Current and Emerging Immunotherapy Strategies in Advanced Urothelial Cancers
Small Cell Transformation: An Increasingly Common Mechanism of Resistance in EGFR-Mutated Lung Cancer
>> View Peer-Reviewed Articles
Most Popular
Overcoming Resistance to Immunotherapy Requires Advanced Strategies
Conventional Views May Not Apply to All Triple-Negative Breast Cancers
Wierda Compares Treatment Options for Patients With CLL
Glioblastoma Expert Calls for Changes to Clinical Trial Design
